http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004143100-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-461 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-46 |
| filingDate | 2003-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1cc91e062d6f94c155450fefd0833443 |
| publicationDate | 2004-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2004143100-A1 |
| titleOfInvention | High affinity humanized monoclonal antibodies |
| abstract | A monoclonal antibody or fragment thereof, wherein at least the hyper variable region is from a monoclonal antibody having an affinity of at least 10 11 1/mol, and at least the constant region (or, if no constant region, the variable region) is derived from human immunoglobulin. The high-affinity monoclonal is from sheep or another mammal that gives higher affinity than a rodent. |
| priorityDate | 1991-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 39.